OpenBilldrug price receipt

NADAC week of 2026-10-14

TADALAFIL 10 MG TABLET

For 30 tablets

Pharmacies pay

$4.60 filed

30 × $0.15341 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$10.29 estimated

$4.60 + $0.69 (15%) + $5.00 fee per fill = $10.29

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TADALAFIL 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tadalafil.

FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.

FDA lists 18 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals, Inc., Torrent Pharmaceuticals Limited and NorthStar RxLLC.

FDA’s Established Pharmacologic Class for it is Phosphodiesterase 5 Inhibitor.

The NADAC file of 2026-10-14 prices it under 28 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.60 for 30 tablets (30 × $0.15341 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 18 labelers

LabelerNDCsPharmacies pay per unit
Solco Healthcare US, LLC4$0.15341 per EA filed
Accord Healthcare Inc.2$0.15341 per EA filed
Ajanta Pharma USA Inc.2$0.15341 per EA filed
Alembic Pharmaceuticals Inc.2$0.15341 per EA filed
Umedica Laboratories USA Inc.2$0.15341 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.15341 per EA filed
Upsher-Smith Laboratories, LLC2$0.15341 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.15341 per EA filed
Amneal Pharmaceuticals NY LLC1$0.15341 per EA filed
Burel Pharmaceuticals, LLC1$0.15341 per EA filed
Camber Pharmaceuticals, Inc.1$0.15341 per EA filed
Dr.Reddys Laboratories Inc1$0.15341 per EA filed
HEC Pharm USA Inc.1$0.15341 per EA filed
Macleods Pharmaceuticals Limited1$0.15341 per EA filed
NIVAGEN PHARMACEUTICALS, INC.1$0.15341 per EA filed
NorthStar RxLLC1$0.15341 per EA filed
Teva Pharmaceuticals, Inc.1$0.15341 per EA filed
Torrent Pharmaceuticals Limited1$0.15341 per EA filed
All 28 NDCs, with labeler and price
  • 00480-2310-56 · Teva Pharmaceuticals, Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 13668-0567-30 · Torrent Pharmaceuticals Limited · $0.15341 per EA · eff. 2026-09-23 filed
  • 16714-0076-01 · NorthStar RxLLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 16729-0371-10 · Accord Healthcare Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 16729-0371-16 · Accord Healthcare Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 24979-0729-06 · Upsher-Smith Laboratories, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 24979-0729-69 · Upsher-Smith Laboratories, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 27241-0113-03 · Ajanta Pharma USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 27241-0113-05 · Ajanta Pharma USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 29300-0288-05 · Unichem Pharmaceuticals (USA), Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 29300-0288-13 · Unichem Pharmaceuticals (USA), Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 31722-0645-30 · Camber Pharmaceuticals, Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 33342-0267-07 · Macleods Pharmaceuticals Limited · $0.15341 per EA · eff. 2026-09-23 filed
  • 35573-0462-30 · Burel Pharmaceuticals, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 43547-0032-03 · Solco Healthcare US, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 43547-0050-03 · Solco Healthcare US, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 43547-0050-11 · Solco Healthcare US, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 43547-0050-50 · Solco Healthcare US, LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 43598-0574-30 · Dr.Reddys Laboratories Inc · $0.15341 per EA · eff. 2026-09-23 filed
  • 60290-0029-01 · Umedica Laboratories USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 60290-0029-02 · Umedica Laboratories USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 62332-0179-30 · Alembic Pharmaceuticals Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 62332-0179-91 · Alembic Pharmaceuticals Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 68382-0898-06 · Zydus Pharmaceuticals USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 68382-0898-10 · Zydus Pharmaceuticals USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 69238-1348-03 · Amneal Pharmaceuticals NY LLC · $0.15341 per EA · eff. 2026-09-23 filed
  • 72303-0824-01 · HEC Pharm USA Inc. · $0.15341 per EA · eff. 2026-09-23 filed
  • 75834-0249-01 · NIVAGEN PHARMACEUTICALS, INC. · $0.15341 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

8 other products in the NADAC file share the FDA nonproprietary name tadalafil with TADALAFIL 10 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ALYQ 20 MG TABLET
generic · tablet, film coated
$0.14633 per EA filed
eff. 2026-09-23
$17.34198 per EA filed
Part D 2024 average
CIALIS 5 MG TABLET
brand · tablet, film coated
$9.20446 per EA filed
eff. 2026-09-23
$9.68261 per EA filed
Part D 2024 average
CIALIS 10 MG TABLET
brand · tablet, film coated
$53.6874 per EA filed
eff. 2026-03-18
$9.68261 per EA filed
Part D 2024 average
CIALIS 20 MG TABLET
brand · tablet, film coated
$53.82543 per EA filed
eff. 2026-09-23
$9.68261 per EA filed
Part D 2024 average
TADALAFIL 2.5 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.11265 per EA filed
eff. 2026-09-23
We don’t know yet
TADALAFIL 5 MG TABLET
generic · tablet, film coated / tablet / tablet, coated
$0.10319 per EA filed
eff. 2026-09-23
We don’t know yet
TADALAFIL 10 MG TABLET this page
generic · tablet, film coated / tablet / tablet, coated
$0.15341 per EA filed
eff. 2026-09-23
We don’t know yet
TADALAFIL 20 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.14633 to $0.16709 per EA filed
eff. 2026-09-23
We don’t know yet
TADLIQ 20 MG/5 ML SUSPENSION
brand · suspension
$13.59311 per ML filed
eff. 2026-10-01
$12.21944 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23, 2026-10-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 28 NDCs’ NADAC prices is $0.15341 per EA filed.

Of the 17 other products in FDA’s Phosphodiesterase 5 Inhibitor class priced per EA, 10 have a higher middle NADAC price and 7 a lower one. The one in the middle is VARDENAFIL HCL 20 MG TABLET, at $2.7928 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.